• small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Investors Overview

Corporate Profile
MiMedx® is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. “Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our bi... More >>
Stock Quote
MDXG (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$11.06
Change (%) Stock is Up 0.01 (0.09%)
Volume287,331
Data as of Nov 28, 2014 1:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Upcoming EventsMore >>
There are currently no events scheduled.
What's New
Download Documentation Investor Presentation
Download Documentation 2012 FDA Inspection Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever MIMEDX GROUP INC posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Products

CONTACT US

888.543.1917